Trial Details

COMPLETED
Basic Information
Clinical ID c477
Identifier NCT03090139
Trial Title Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Colitis, Ulcerative|Crohn Disease|Inflammatory Bowel Diseases
Interventions DRUG: Anti-TNF Therapy
Participant Information
Sponsor Takeda
City Ciudad Autonoma Buenos Aires
Country/Region Argentina
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase -
Time Information
Start Date 2017-03-28
Primary Completion Date 2018-06-13
Completion Date 2018-06-13